Display options
Share it on

Rare Dis. 2016 Jun 22;4(1):e1198458. doi: 10.1080/21675511.2016.1198458. eCollection 2016.

Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.

Rare diseases (Austin, Tex.)

Moones Heidari, Sam H Gerami, Brianna Bassett, Ross M Graham, Anita C G Chua, Ritambhara Aryal, Michael J House, Joanna F Collingwood, Conceição Bettencourt, Henry Houlden, Mina Ryten, John K Olynyk, Debbie Trinder, Daniel M Johnstone, Elizabeth A Milward

Affiliations

  1. School of Biomedical Sciences and Pharmacy, The University of Newcastle , Callaghan, NSW, Australia.
  2. School of Biomedical Sciences & Curtin Health Innovation Research Institute - Biosciences, Curtin University of Technology , Bentley, WA, Australia.
  3. School of Medicine and Pharmacology, University of Western Australia, Fiona Stanley Hospital, Murdoch, WA, Australia; Harry Perkins Institute of Medical Research, Murdoch, WA, Australia.
  4. School of Physics, University of Western Australia , Crawley, WA, Australia.
  5. Warwick Engineering in Biomedicine, School of Engineering, University of Warwick , Coventry, UK.
  6. Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK.
  7. Department of Molecular Neuroscience, UCL Institute of Neurology , London, UK.
  8. Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Department of Medical and Molecular Genetics, King's College London, London, UK.
  9. School of Biomedical Sciences & Curtin Health Innovation Research Institute - Biosciences, Curtin University of Technology, Bentley, WA, Australia; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia; Department of Gastroenterology and Hepatology, Fiona Stanley Hospital, Murdoch, WA, Australia; Department of Gastroenterology and Hepatology, Fremantle Hospital, Fremantle, WA, Australia.
  10. Bosch Institute and Discipline of Physiology, University of Sydney , Sydney, NSW, Australia.

PMID: 27500074 PMCID: PMC4961263 DOI: 10.1080/21675511.2016.1198458

Abstract

We previously demonstrated elevated brain iron levels in myelinated structures and associated cells in a hemochromatosis Hfe (-/-) xTfr2 (mut) mouse model. This was accompanied by altered expression of a group of myelin-related genes, including a suite of genes causatively linked to the rare disease family 'neurodegeneration with brain iron accumulation' (NBIA). Expanded data mining and ontological analyses have now identified additional myelin-related transcriptome changes in response to brain iron loading. Concordance between the mouse transcriptome changes and human myelin-related gene expression networks in normal and NBIA basal ganglia testifies to potential clinical relevance. These analyses implicate, among others, genes linked to various rare central hypomyelinating leukodystrophies and peripheral neuropathies including Pelizaeus-Merzbacher-like disease and Charcot-Marie-Tooth disease as well as genes linked to other rare neurological diseases such as Niemann-Pick disease. The findings may help understand interrelationships of iron and myelin in more common conditions such as hemochromatosis, multiple sclerosis and various psychiatric disorders.

Keywords: NBIA; array; brain; hemochromatosis; iron; myelin; neurodegeneration; oligodendrocyte

References

  1. Trends Genet. 1999 Apr;15(4):125-8 - PubMed
  2. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14714-9 - PubMed
  3. Nat Neurosci. 2005 Apr;8(4):468-75 - PubMed
  4. FASEB J. 2006 Apr;20(6):720-2 - PubMed
  5. Am J Med Genet A. 2009 May;149A(5):1081 - PubMed
  6. J Neurochem. 2010 Jun;113(6):1387-402 - PubMed
  7. Neurochem Int. 2010 May-Jun;56(6-7):856-63 - PubMed
  8. J Neurol. 2010 Sep;257(9):1465-72 - PubMed
  9. Clin Genet. 2010 Dec;78(6):585-90 - PubMed
  10. Aging (Albany NY). 2010 Sep;2(9):567-81 - PubMed
  11. J Neurosci. 2011 Sep 14;31(37):13301-11 - PubMed
  12. Am J Med Genet A. 2011 Nov;155A(11):2647-53 - PubMed
  13. Brain Res. 2012 Apr 11;1448:144-52 - PubMed
  14. Hepatology. 2012 Aug;56(2):585-93 - PubMed
  15. Neuropathol Appl Neurobiol. 2013 Feb;39(2):121-31 - PubMed
  16. Neuroscience. 2013 Apr 3;235:119-28 - PubMed
  17. Mov Disord. 2014 Apr;29(4):574-5 - PubMed
  18. J Biol Chem. 2014 Aug 29;289(35):24700-15 - PubMed
  19. Am J Med Genet A. 2014 Dec;164A(12):3095-9 - PubMed
  20. J Neurochem. 2015 Dec;135(5):958-74 - PubMed
  21. Sci Rep. 2015 Sep 18;5:14235 - PubMed
  22. PLoS One. 2015 Oct 09;10(10):e0139914 - PubMed
  23. Neurobiol Dis. 2016 Mar;87:59-68 - PubMed
  24. Mol Psychiatry. 2016 Nov;21(11):1599-1607 - PubMed
  25. Microarrays (Basel). 2013 May 21;2(2):131-52 - PubMed
  26. Nature. 1997 Nov 6;390(6655):45-51 - PubMed

Publication Types

Grant support